Ocular Therapeutix (OCUL) Other Non Operating Income (2013 - 2026)

Ocular Therapeutix's Other Non Operating Income history runs 13 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 248.77% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was -$38000.0, a 101.24% decrease from a year earlier, with the FY2025 full-year figure at -$2.5 million, up 91.16% from the prior year.
• Other Non Operating Income rose to $1.5 million in Q1 2026 per OCUL's latest filing, from $595000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $12.9 million in Q4 2023 and bottomed at -$28.0 million in Q1 2024.
• The 5-year median for Other Non Operating Income is $863000.0 (2023), against an average of $194625.0.
• Across the five-year window, Other Non Operating Income soared 693.29% in 2023 and sank 367.64% in 2024, its largest moves.
• Year by year, Other Non Operating Income stood at $5.2 million in 2022, then surged by 146.04% to $12.9 million in 2023, then plunged by 45.15% to $7.1 million in 2024, then slumped by 91.59% to $595000.0 in 2025, then jumped by 144.54% to $1.5 million in 2026.
• Per Business Quant, the three latest OCUL Other Non Operating Income figures stand at $1.5 million (Q1 2026), $595000.0 (Q4 2025), and -$1.4 million (Q3 2025).